em.mbeki
Submits third-party assay reports on material purchased directly. Based in Konya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
98.61%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043316 | Tirzepatide | CPC | CPC-2607-L2552 | Janoshik | 2026-Q3 | 96.14 | 5.00 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-042566 | Tirzepatide | ERP | ERP-2512-T7433 | Medutest | 2026-Q2 | 99.36 | 1.63 | 99.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043307 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | Janoshik | 2026-Q1 | 98.16 | 7.72 | 106.0 | Supplier-supplied | 0 | FAIL |
| AX-2025-020160 | Liraglutide | GGPeps | GGPE-2505-W9629 | Nordanalyt | 2025-Q4 | 98.61 | 7.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020825 | GHRP-6 | SGN | SGN-2504-X1136 | Janoshik | 2025-Q3 | 98.48 | 4.48 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-019477 | BPC-157 | Homopeptide | HOMO-2411-K9540 | Nordanalyt | 2025-Q1 | 99.54 | 4.10 | 95.5 | Supplier-supplied | 0 | PASS |
| AX-2024-004864 | Semaglutide | SWB | SWB-2409-C6095 | Janoshik | 2024-Q4 | 98.50 | 6.00 | 92.6 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004695 | Liraglutide | TFC | TFC-2406-V7696 | PeptideMeter | 2024-Q3 | 99.61 | 5.16 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004121 | Semax | WWB | WWB-2308-N1754 | VendorInvestigate | 2024-Q1 | 98.89 | 4.92 | 96.0 | Buyer-sourced | 0 | PASS |